Quantitative Systematic Strategies LLC Verona Pharma PLC Transaction History
Quantitative Systematic Strategies LLC
- $0
- Q3 2022
Shares
3 transactions
Others Institutions Holding VRNA
# of Institutions
166Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$221 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$195 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$175 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$147 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$124 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.13B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...